Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ana Ávila-Alonso"'
Autor:
Josué Pendones Ulerio, Mar Redero Cascón, Alejandra Maria Parra Morales, Juan Luis Muñoz Bellido, Ana Ávila Alonso
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 42:793-796
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86a57aafdf422075db205939b63da32a
https://doi.org/10.1007/s10096-023-04598-6
https://doi.org/10.1007/s10096-023-04598-6
Autor:
Milagros González-Rivera, José María Eiros, Eduardo Tamayo, Ana Ávila-Alonso, Raquel Almansa, Jesus F. Bermejo-Martin
Publikováno v:
Emerging Infectious Diseases, Vol 22, Iss 7, Pp 1265-1267 (2016)
Emerging Infectious Diseases
Emerging Infectious Diseases
Diphtheria antitoxin for therapeutic use is in limited supply. A potential source might be affinity-purified antibodies originally derived from plasma of adults who received a booster dose of a vaccine containing diphtheria toxoid. These antibodies m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2863c31005f0748ca88f5fc8d316c5f1
https://wwwnc.cdc.gov/eid/article/22/7/15-1670_article
https://wwwnc.cdc.gov/eid/article/22/7/15-1670_article
Autor:
Jesus F. Bermejo-Martin, Diana Benavides, Cesar Aldecoa, Francisco Blanco-Antona, José Ignacio Gómez-Herreras, Juan Beltran de Heredia, Jesús Rico, Pilar Liu, Ana Ávila-Alonso, Silvia Martín, C. Andres, Marta Martín-Fernández, Marta Aragón, Iñigo López de Cenarruzabeitia, María Heredia-Rodríguez, Raquel Almansa, Dolores Calvo, Eduardo Tamayo, Lydia Blanco, David Andaluz-Ojeda, Esther Gómez-Sánchez, Lucia Rico, Alicia Ortega
Publikováno v:
Annals of surgery. 269(3)
To quantify immunological dysfunction in surgical patients with presence/absence of sepsis using a droplet digital polymerase chain reaction (ddPCR) transcriptomic analysis. The study also aims to evaluate this approach for improving identification o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeb6526754a7db0553e806271e8095ba
https://pubmed.ncbi.nlm.nih.gov/28692472
https://pubmed.ncbi.nlm.nih.gov/28692472
Autor:
Alberto, Tenorio-Abreu, Jesús, Gil Tomás, Miguel Ángel, Bratos Pérez, Alberto, de la Iglesia Salgado, María, Borrás Máñez, Raúl, Ortiz de Lejarazu Leonardo, Ana, Ávila Alonso, Javier, Colomina Rodríguez, Juan Antonio, Pérez Cáceres, José María, Saavedra Martín, Adriana, Márquez Sanabria, Ana, Domínguez Castaño, Matilde, de la Iglesia Salgado
Publikováno v:
Enfermedades infecciosas y microbiologia clinica. 33(2)
Ceftaroline fosamil is a new-generation antimicrobial agent of cephalosporins subgroup. It is the first commercially available beta-lactam antibiotic that exhibits activity against methicillin-resistant Staphylococcus aureus (MRSA). The aim of this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8942227347a1e846253292ddbb41177a
https://pubmed.ncbi.nlm.nih.gov/25091384
https://pubmed.ncbi.nlm.nih.gov/25091384
Autor:
José María Eiros, Esther Gómez-Sánchez, Lucia Rico, Ana Rodriguez-Fernandez, Jose Ignacio Gómez Herreras, Verónica Iglesias, Jesus F. Bermejo-Martin, John Wain, Elena Carrasco, Eduardo Tamayo, David Andaluz-Ojeda, María Heredia, Susana Soria, Raquel Almansa, Ana Ávila-Alonso, Ángel Martínez-Martínez
Publikováno v:
UVaDOC. Repositorio Documental de la Universidad de Valladolid
instname
Critical Care
instname
Critical Care
Producción Científica
Evaluation of host immune response to infection at the molecular level is a promising avenue to obtain diagnostic and prognostic tools for the clinical management of patients with sepsis. A recent report from Cajander and
Evaluation of host immune response to infection at the molecular level is a promising avenue to obtain diagnostic and prognostic tools for the clinical management of patients with sepsis. A recent report from Cajander and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34a605b4042ed68b4f657f520abef54b
https://doi.org/10.1186/cc13910
https://doi.org/10.1186/cc13910
Autor:
Jesús F. Bermejo-Martin, Ana Avila-Alonso, Milagros González-Rivera, Eduardo Tamayo, Jose María Eiros, Raquel Almansa
Publikováno v:
Emerging Infectious Diseases, Vol 22, Iss 7, Pp 1265-1267 (2016)
Diphtheria antitoxin for therapeutic use is in limited supply. A potential source might be affinity-purified antibodies originally derived from plasma of adults who received a booster dose of a vaccine containing diphtheria toxoid. These antibodies m
Externí odkaz:
https://doaj.org/article/0d98f660e5b247599715a92e24c99902